68Ga-PSMA-11 PET for the Diagnosis of Biochemically Recurrent Prostate Cancer

NCT04216134 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Biochemically Recurrent Prostate Carcinoma

Interventions

DRUG: Gallium Ga 68-labeled PSMA-11
PROCEDURE: Positron Emission Tomography

Sponsor

City of Hope Medical Center

Collaborators

[object Object]